Integration of Nova's BioProfile® FLEX2 will enable automated cell culture analyses for process development through commercial manufacturing with Quantum Flex
Nova Biomedical today announced the availability of the Nova Primary™ glucose reference analyzer, filling the need left by the discontinued YSI 2300 STAT PLUS Glucose and L-Lactate analyzer (YSI, Inc., Yellow Springs, OH).
Biomedical is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for a micro capillary sample mode on the Stat Profile Prime Plus® Critical Care analyzer.
Featuring five lessons, the new curriculum is designed to help students in grades 1–3 understand how artificial intelligence works and what its limitations are.
Rope-like bands of internal scar tissue that form in 70-90% of patients who undergo abdominal surgery have bedeviled patients and surgeons since medical literature history's recording of adhesions in 1836
LMTK3 as prognostic marker for ovarian cancer and TTX335o, award-winning drug candidate with tumor-killing activity, presented as game-changing treatment for women
Nova Biomedical is pleased to announce the launch of BioProfile FAST CDV, a high-throughput, fully automated viable cell density and viability analyzer capable of producing results in under 70 seconds with just 100μL of sample volume.
